Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

More documents

Recommendations

Info

APPENDIX 3 – SURVEY REGARDING PRACTICES IN THE NETWORK 3.2.7 Patient Care (Chapter 11) COMPLIANCE CRITERIA The patient is given a comprehensive information sheet regarding cytotoxic drugs and the preventive measures to limit exposure, in order to reduce the risk of contamination during treatment (e.g. precautions regarding excreta, how to deal with family, etc.). (n = 3) COMPLIANCE RATE (%) 57 3.2.8 Management of Waste, Accidental Exposure, Spills and Returns (Chapter 12) COMPLIANCE CRITERIA All disposable material used for the administration of antineoplastic drugs is discarded in containers marked “cytotoxic products”. (n = 53) There is a complete spill management kit (i.e., materials, procedure, protective equipment, etc.) in the Pharmacy Department. (n = 53) There is a complete spill management kit (i.e., materials, procedure, protective equipment, etc.) in the targeted care units. (n = 52) The bag containing the antineoplastic drug and the attached administration tubing are discarded as a unit (i.e., without being disconnected). (n = 52) COMPLIANCE RATE (%) 98 94 69 94 In a spring 2006 survey of Pharmacy Department Heads and Nursing Directors in Quebec health care institutions with a minimum of 50 short-term care beds and oncology activities, there were no particular findings regarding the laundry. 3.2.9 Hygiene and Sanitation (Chapter 13) COMPLIANCE CRITERIA The equipment used by the housekeeping workers to clean the pharmacy areas dedicated to the handling/preparation of hazardous and cytotoxic drugs is not used to clean other areas of the hospital. (n = 52) COMPLIANCE RATE (%) 38 3.2.10 Laundry (Chapter 14) The survey revealed no particular findings regarding the laundry. A3-6 ASSTSAS PREVENTION GUIDE – SAFE HANDLING OF HAZARDOUS DRUGS
APPENDIX 3 – SURVEY REGARDING PRACTICES IN THE NETWORK 3.2.11 Medical, Biological and Environmental Monitoring COMPLIANCE CRITERIA The institution has known, defined criteria regarding the reassignment of a pregnant worker exposed to hazardous and cytotoxic drugs. (n = 51) The Pharmacy Department uses a cytotoxic drug exposure record (i.e., is able to identify the workers exposed and the length of exposure per year). (n = 53) The institution offers a medical monitoring program to pharmacy workers exposed to hazardous and cytotoxic drugs (e.g. annual hemogram, consultation with a physician, etc.). (n = 53) The institution offers a medical monitoring program to the nursing staff exposed to hazardous and cytotoxic drugs (e.g. annual hemogram, consultation with a physician, etc.). (n = 52). The Pharmacy Department checks the surface contamination in the pharmacy due to hazardous and cytotoxic drugs (i.e., measurement of trace residues) annually. (n = 53) The Pharmacy Department carries out microbiological monitoring of its preparation cabinets at least once a week (i.e., using sedimentation with agar). (n = 53) COMPLIANCE RATE (%) 73 26 21 17 2 4 A study of practice compliance will be carried out in health care institutions in 2008, following the distribution of this guide. In addition, it should be noted that a Canadian survey regarding sterile drug preparations (in relation to Chapter 797 of the United States Pharmacopoeia), including hazardous drugs, was conducted in the spring of 2007. The situation in Quebec was described in Pharmactuel 2007; 40(4): 228-31 (http://www.pharmactuel.com/sommaires/200704ge.pdf), while the situation in Canada will be described in 2008 in the Canadian Journal of Hospital Pharmacy. PREVENTION GUIDE – SAFE HANDLING OF HAZARDOUS DRUGS ASSTSAS A3-7
Page 1 and 2:
Prevention Guide Safe Handling of H
Page 3 and 4:
Prevention Guide Safe Handling of H
Page 5 and 6:
This guide has been developed by th
Page 7 and 8:
Table of Contents PREAMBLE ........
Page 9 and 10:
List of Tables Table 1 Medication C
Page 11:
PREAMBLE In September 2004, the Uni
Page 14 and 15:
1. INTRODUCTION 1.1.1 Survey Regard
Page 16 and 17:
1. INTRODUCTION 1.3 Guide Structure
Page 19 and 20:
2. RISKS RELATED TO THE USE OF HAZA
Page 21 and 22:
Page 23 and 24:
Pharmacy Care Wastes Support Receiv
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31:
Page 34 and 35:
3. PREVENTION OBJECTIVES AND ACTION
Page 37 and 38:
4. GENERAL PREVENTIVE MEASURES 4 GE
Page 39 and 40:
4. GENERAL PREVENTIVE MEASURES 4.1.
Page 41 and 42:
4. GENERAL PREVENTIVE MEASURES 4.1.
Page 43 and 44:
4. GENERAL PREVENTIVE MEASURES clea
Page 45 and 46:
4. GENERAL PREVENTIVE MEASURES Tabl
Page 47:
4. GENERAL PREVENTIVE MEASURES Gras
Page 50 and 51:
5. RECEIVING AND TRANSPORT 5.3.2 De
Page 53 and 54:
6. UNPACKING AND STORAGE 6 UNPACKIN
Page 55 and 56:
6. UNPACKING AND STORAGE 6.3.3 Unpa
Page 57:
6. UNPACKING AND STORAGE 6.3.6 Spil
Page 60 and 61:
7. PLANNING THE ONCOLOGY PHARMACY 7
Page 62 and 63:
7. PLANNING THE ONCOLOGY PHARMACY
Page 64 and 65:
7. PLANNING THE ONCOLOGY PHARMACY b
Page 66 and 67:
Fridge 7. PLANNING THE ONCOLOGY PHA
Page 68 and 69:
7. PLANNING THE ONCOLOGY PHARMACY T
Page 70 and 71:
8. DRUG PREPARATION The product nev
Page 72 and 73:
8. DRUG PREPARATION ‣ avoid sudde
Page 74 and 75:
8. DRUG PREPARATION or “Caution
Page 76 and 77:
8. DRUG PREPARATION 8.3.9 Preparing
Page 78 and 79:
8. DRUG PREPARATION Wearing both
Page 80 and 81:
9. TRANSPORT AND STORAGE FOLLOWING
Page 82 and 83:
10. ADMINISTRATION OF DRUGS Adminis
Page 84 and 85:
10. ADMINISTRATION OF DRUGS Nurses
Page 86 and 87:
10. ADMINISTRATION OF DRUGS Primary
Page 88 and 89:
10. ADMINISTRATION OF DRUGS Establi
Page 90 and 91:
10. ADMINISTRATION OF DRUGS if a o
Page 92 and 93:
10. ADMINISTRATION OF DRUGS 10.3.10
Page 94 and 95:
10. ADMINISTRATION OF DRUGS 10.3.13
Page 96 and 97: 10. ADMINISTRATION OF DRUGS contain
Page 99 and 100: 11. PATIENT CARE 11 PATIENT CARE 11
Page 101 and 102: 11. PATIENT CARE arrive (see 13.3.1
Page 103: 11. PATIENT CARE Table 8. Hazardous
Page 106 and 107: 12. MANAGEMENT OF WASTE, ACCIDENTAL
Page 112 and 113: 13. HYGIENE AND SANITATION 13.2 Exp
Page 115: 14. LAUNDRY 14 LAUNDRY 14.1 Issues
Page 118 and 119: 15. MEDICAL, BIOLOGICAL AND ENVIRON
Page 120 and 121: 15. MEDICAL, BIOLOGICAL AND ENVIRON
Page 123 and 124: 16. REFERENCES 16 REFERENCES AHQ [1
Page 125: 16. REFERENCES Nygren O., Lundgren
Page 129 and 130: APPENDIX 1 - GLOSSARY APPENDIX 1- G
Page 131 and 132: APPENDIX 1 - GLOSSARY TERMS DEFINIT
Page 133: APPENDIX 1 - GLOSSARY TERMS DEFINIT
Page 136 and 137: APPENDIX 2 - LIST OF HAZARDOUS DRUG
Page 142 and 143: APPENDIX 3 - SURVEY REGARDING PRACT
Page 144 and 145: APPENDIX 3 - SURVEY REGARDING PRACT
Page 149 and 150: APPENDIX 4 - HAZARDOUS SPILL MANAGE
Page 151 and 152: APPENDIX 4 - HAZARDOUS SPILL MANAGE
Page 153 and 154: 5. MEASUREMENT OF WORK SURFACE CONT
show all

Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?